FDA DEVICE FACTS
CS-series-FP Radiographic / Fluoroscopic Systems with Optional CA-100S / FluoroShield (ROI Assembly)
Omega Medical Imaging, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Omega Medical Imaging, LLC CS-series-FP (SSXI) systems with optional accessory device CA- 100S as a modification device to provide an automated Region of interest that manages exposure to the patient and operator. The System is intended for use in Radiographic/fluoroscopic applications including cardiac, vascular, general radiographic/fluoroscopic diagnostic, and interventional x-ray imaging for General Populations. At no time will the CA-100S be considered as a replacement for the primary collimator. The primary collimator shall always be used, in accordance with good medical practice, to define a Region of Interest
The Omega Medical Imaging, LLC CS-series-FP (SSXI) systems with optional accessory device CA- 100S as a modification device to provide an automated Region of interest that reduces exposure to the patient and operator. The System is intended for use in Radiographic/fluoroscopic applications including cardiac, vascular, general radiographic/fluoroscopic diagnostic, and interventional x-ray imaging for General Populations. At no time will the CA-100S be considered as a replacement for the primary collimator. The primary collimator shall always be used, in accordance with good medical practice, to define a Region of Interest
Classificati on Name: Image-intensified Fluoroscopic X-ray system Image-intensified Fluoroscopic X-ray system CFR Regulation #: 892.1650 892.1650 Device Class Class II Class II Classificati on Product Code: JAA, OWB JAA, OWB
PRODUCT OVERVIEW The CA-100S / FluoroShield™ is a secondary collimator that can only be used in conjunction with the primary collimator. When using the CA-100S / FluoroShield™, the primary collimator shall be used to manually define a region of interest. Once this ROI has been established by the primary collimator, the CA-100S / FluoroShield™ can be used to further reduce the size of the ROI beyond the ROI initially established with the primary collimator. Due to the reduction in size of the ROI, the CA-100S/ FluoroShield™ can offer a reduction in Dose Area Product to patients and medical staff by reducing the area of exposure. At no time will the CA-100S/ FluoroShield™ be considered as a replacement for the primary collimator. The primary collimator shall always be used, in accordance with good medical practice, to define a ROI. Additional testing for this submission was performed utilizing a DAP meter to demonstrate the dose reduction results utilizing the CA-100S / FluoroShield™ accessory. A clinical study was conducted sampling 100 patients as well to demonstrate the dose reduction to patients and staff.
Predicate device Omega CS-series-FP utilizes the CA-100S. The only difference for this submission is use of the CA-100S with a smaller Varex 2020 FPD that is 20cm x 20cm verses the predicate device that utilizes a Varex 3030 FPD that is 30cm x 30cm.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。